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0.0001) and (IL-4: 0.1 ± 0.1 vs. 1.02 ± 1.7 ng/ml, p = 0.0112)]. 
No significant changes in TNF-α, IL-6, EDSS and MMP-9 were 
found between the LA and placebo groups (p = 0.6, p = 0.8, 
p = 0.09 and p = 0.8, respectively).  Conclusion: The results 
suggested that consumption of 1,200 mg LA per day benefi-
cially affects several inflammatory cytokines including INF-γ, 
ICAM-1 TGF-β and IL-4. Further investigations are needed to 
verify the beneficial role of LA on other cytokine profiles 
among MS patients.  © 2014 S. Karger AG, Basel 
 Introduction 
 Multiple sclerosis (MS) is a chronic disabling autoim-
mune and demyelination disease of the central nervous 
system (CNS)  [1, 2] . High levels of proinflammatory fac-
tors, the increasing production of free radicals and oxida-
tive stress in CNS are related to the pathogenesis of this 
disease  [3] . It seems that both genetic and environmental 
factors play an important role in the incidence and devel-
opment of MS  [4–6] . The prevalence of MS has increased 
globally  [7, 8] . Recent evidence points to a high and in-
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 Abstract 
 Background: A limited amount of data exists regarding the 
effect of lipoic acid (LA), an oral antioxidant supplement, on 
cytokine profiles among multiple sclerosis (MS) patients.  Ob-
jective: We aimed to assess the effect of daily consumption 
of LA on the cytokine profiles in MS patients.  Methods: In this 
double-blind, placebo-controlled, randomized clinical trial, 
52 relapsing-remitting MS patients with an age range of 18–
50 years were recruited into 2 groups: LA consumption 
(1,200 mg/day) or placebo. Patients followed their pre-
scribed supplements for 12 weeks. Fasting blood samples for 
cytokine profile measurement were collected at baseline 
and after the intervention. Anthropometric parameters were 
measured based on the standard guidelines.  Results: INF-γ, 
ICAM-1, TGF-β and IL-4 were significantly reduced in the LA 
group compared to the placebo group [(INF-γ: 0.82 ± 0.2 vs. 
0.2 ± 0.2 pg/ml, p < 0.0001), (ICAM-1: 20.2 ± 9.4 vs. 8 ± 10 ng/
ml, p = 0.0001), (TGF-β: 103.1 ± 20.2 vs. 54.9 ± 26 ng/ml, p < 
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